期刊文献+

原发韦氏环非霍奇金淋巴瘤50例临床特征和预后分析 被引量:2

Clinical characteristics and prognosis analysis of 50 patients with primary Waldeyer's ring non-Hodgkin lymphoma
原文传递
导出
摘要 目的比较原发韦氏环非霍奇金淋巴瘤(WRNHL)常见病理类型的临床特征与预后差异。方法对2008年1月至2013年12月收治的50例原发WRNHL患者的临床资料进行回顾性分析。Kaplan-Meier法计算生存率,用Log-rank法检验组间差异并行单因素预后分析。结果原发WRNHL常见病理类型为弥漫大B细胞淋巴瘤(DLBCL)与结外鼻型NK/T细胞淋巴瘤(ENKTCL),其中DLBCL占56%(28/50),ENKTCL占34%(17/50)。DLBCL的发病年龄明显大于ENKTCL,两者原发部位不同,50.0%(14/28)的DLBCL患者原发于扁桃体,88.2%(15/17)的ENKTCL原发于鼻咽部;DLBCL的近期疗效远优于ENKTCL,DLBCL的总生存率、无进展生存率均优于ENKTCL,差异均有统计学意义(χ2=4.45,P=0.035;χ2=6.47,P=0.011)。结论DLBCL和ENKTCL的临床特征不同,DLBCL的近期疗效及预后明显优于ENKTCL。 Objective To compare the clinicopathological characteristics and prognosis of primary Waldeyer's ring non-Hodgkin lymphoma. Methods From Jan 2008 to Dec 2013, 50 patients with primary Waldeyer's ring non-Hodgkin lymphoma were retrospectively analyzed. Kaplan-Meier method was used for survival analysis. Log-rank method was used for univariate analysis. Results Waldeyer's ring diffuse large B-cell lymphoma (DLBCL) and extranodal nasal-type NK/T-cell lymphoma (ENKTCL) were the common pathological types of primary Waldeyer's ring non-Hodgkin ]ymphoma accounting for 56 % (28/50) DLBCL and 34 % (17/50) ENKTCL, respectively. The age at onset of ENKTCL patients was younger than that of DLBCL patients. Two groups had different primary sites, including 50.0 % (14/28) of DLBCL with tonsillar disease and 88.2 % (15/17) of ENKTCL with nasopharynx disease. The short phase effect of DLBCL group was higher than that of ENKTCL group. The overall survival (OS) and progression-free survival (PFS) rates had significant differences between DLBCL and ENKTCL (χ2 = 4.45, P = 0.035; χ2 = 6.47, P = 0.011). Conclusion DLBCL and ENKTCL are different in clinical characteristics. The short phase effect and prognosis of DLBCL are obviously better than those of the ENKTCL.
出处 《白血病.淋巴瘤》 CAS 2015年第9期548-550,共3页 Journal of Leukemia & Lymphoma
关键词 淋巴瘤 非霍奇金 韦氏环 预后 Lymphoma, non-Hodgkin's Waldeyer's ring Prognosis
  • 相关文献

参考文献16

  • 1Mok TS,Steinberg J,Chan AT,et al.Application of the international prognostic index in a study of Chinese patients with non-Hodgkin's lymphoma and a high incidence of primary extranodal lymphoma[J].Cancer,1998,82(12):2439-2448.
  • 2Cheson BD,Horning SJ,Coiffier B,et al.Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas.NCI Sponsored International Working Group[J].J Clin Oncol,1999,17(4):1244.
  • 3Ko YH,Kim CW,Park CS,et al.REAL classification of malignant lymphomas in the Republic of Korea:incidence of recently recognized entities and changes in clinicopathologic features.Hematolympho-reticular Study Group of the Korean Society of Pathologists.Revised European-American lymphoma[J].Cancer,1998,83(4):806-812.
  • 4Ezzat AA,Ibrahim EM,El Weshi AN,et al.Localized non-Hodgkin's lymphoma of Waldeyer's ring:clinical features,management,and prognosis of 130 adult patients[J].Head Neck,2001,23(7):547-558.
  • 5张延平,贾胜男,薛学敏,黄欣,李敏,高子芬,李斌斌,刘翠苓.口腔颌面部弥漫大B细胞淋巴瘤69例临床病理分析[J].白血病.淋巴瘤,2014,23(5):270-273. 被引量:1
  • 6Li YX,Liu QF,Fang H,et al.Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma[J].Clin Cancer Res,2009,15(8):2905-2912.
  • 7归薇,关涛,赵瑾,马莉,王晶荣,韩维娥,杨斌,白敏,苏丽萍.鼻外NK/T细胞淋巴瘤21例临床特征及预后分析[J].白血病.淋巴瘤,2014,23(8):480-483. 被引量:2
  • 8李硕,刘暖,王旖旎,张嘉,汤然,黄文秋,曾祥宗,王昭.结外鼻型NK/T细胞淋巴瘤30例诊疗分析[J].白血病.淋巴瘤,2013,22(12):724-728. 被引量:6
  • 9Ko YH,Lee JD,Kim CM,et al.Malignant lymphomas of the nasal cavity and Waldeyer's ring--clinicopathologic and immunohistoche-mical study[J].J Korean Med Sci,1992,7(4):314-324.
  • 10Harabuchi Y,Tsubota H,Ohguro S,et al.Prognostic factors and treatment outcome in non-Hodgkin's lymphoma of Waldeyer's ring[J].Acta Oncol,1997,36(4):413-420.

二级参考文献31

  • 1郭霞,李强,周晨燕.儿童噬血细胞综合征41例临床分析[J].中华血液学杂志,2007,28(7):449-453. 被引量:26
  • 2Jaffe ES,Chan JK,Su IJ,et al.Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas Definitions,differential diagnosis,and epidemiology.Am J Surg Pathol,1996,20:103-111.
  • 3Avilés A,Díaz NR,Neff N,et al.Angioeentric nasal T/natural killer cell lymphoma:a single center study of prognostic factors in 108 patients.Clin Lab Haematol,2000,22:215-220.
  • 4Janka GE.Familial and acquired hemophagocytic lymphohistiocytosis.Eur J Pediatr,2007,166:95-109.
  • 5Chan JK,Sin VC,Wong KF,et al.Nonnasal lymphoma expressing the natural killer cell marker CD56:a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.Blood,1997,89:4501-4513.
  • 6Ma HH,Qian LT,Pan HF,et al.Treatment outcome of radiotherapy alone versus radiochemotherapy in early stage nasal natural killer/Tcell lymphoma.Med Oncol,2010,27:798-806.
  • 7Kim SJ,Kim BS,Choi CW,et al.Treatment outcome of front-line systemic chemotherapy for localized ectrnodal NK/T cell lymphoma in nasal and upper aerodigestive tract.Leuk Lymphoma,2006,47:1265-1273.
  • 8Kim SJ,Kim K,Kim BS,et al.Phase Ⅱ trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed,stage Ⅰ E to Ⅱ E,nasal,extranonal NK/T-Cell Lymphoma:Consortium for Improving Survival of Lymphoma study.J Clin Oncol,2009,27:6027-6032.
  • 9WuX,LiP,ZhaoJ,etal.A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma,nasal type.Clin Oncol (R Coll Radiol),2008,20:619-625.
  • 10Yamaguchi M,Suzuki R,Kwong YL,et al.Phase Ⅰ study of dexamethasone,methotrexate,ifosfamide,L-asparaginase,and etoposide (SMILE) chemotherapy for advanced-stage,relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia.Cancer Sci,2008,99:1016-1020.

共引文献6

同被引文献17

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部